Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study
Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women
Patients Prefer Silicone Over Saline Implants
More Breast Cancer Patients Opt To Remove Both Breasts
Small Study: Radiation, Chemo May Better Control Anal Cancer
BRAF Inhibitor Shrank Tumors In Phase II Genentech Study
Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer
Radiotherapy Plus Cetuximab May Control Head/Neck Cancer
Clinical Trials Approved By NCI
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
